177 related articles for article (PubMed ID: 21315178)
1. Cytoplasmic ATM protein kinase: an emerging therapeutic target for diabetes, cancer and neuronal degeneration.
Yang DQ; Halaby MJ; Li Y; Hibma JC; Burn P
Drug Discov Today; 2011 Apr; 16(7-8):332-8. PubMed ID: 21315178
[TBL] [Abstract][Full Text] [Related]
2. ATM protein kinase mediates full activation of Akt and regulates glucose transporter 4 translocation by insulin in muscle cells.
Halaby MJ; Hibma JC; He J; Yang DQ
Cell Signal; 2008 Aug; 20(8):1555-63. PubMed ID: 18534819
[TBL] [Abstract][Full Text] [Related]
3. [Ataxia telangiectasia].
Hosoi H; Sawada T
Nihon Rinsho; 2000 Jul; 58(7):1505-10. PubMed ID: 10921332
[TBL] [Abstract][Full Text] [Related]
4. The ATM gene and ataxia telangiectasia.
Mavrou A; Tsangaris GT; Roma E; Kolialexi A
Anticancer Res; 2008; 28(1B):401-5. PubMed ID: 18383876
[TBL] [Abstract][Full Text] [Related]
5. Constitutive expression and cytoplasmic compartmentalization of ATM protein in differentiated human neuron-like SH-SY5Y cells.
Boehrs JK; He J; Halaby MJ; Yang DQ
J Neurochem; 2007 Jan; 100(2):337-45. PubMed ID: 17241156
[TBL] [Abstract][Full Text] [Related]
6. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study.
Verhagen MM; Last JI; Hogervorst FB; Smeets DF; Roeleveld N; Verheijen F; Catsman-Berrevoets CE; Wulffraat NM; Cobben JM; Hiel J; Brunt ER; Peeters EA; Gómez Garcia EB; van der Knaap MS; Lincke CR; Laan LA; Tijssen MA; van Rijn MA; Majoor-Krakauer D; Visser M; van 't Veer LJ; Kleijer WJ; van de Warrenburg BP; Warris A; de Groot IJ; de Groot R; Broeks A; Preijers F; Kremer BH; Weemaes CM; Taylor MA; van Deuren M; Willemsen MA
Hum Mutat; 2012 Mar; 33(3):561-71. PubMed ID: 22213089
[TBL] [Abstract][Full Text] [Related]
7. The ATM-dependent DNA damage signaling pathway.
Kitagawa R; Kastan MB
Cold Spring Harb Symp Quant Biol; 2005; 70():99-109. PubMed ID: 16869743
[TBL] [Abstract][Full Text] [Related]
8. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer.
Lavin MF
Nat Rev Mol Cell Biol; 2008 Oct; 9(10):759-69. PubMed ID: 18813293
[TBL] [Abstract][Full Text] [Related]
9. ATM and the molecular pathogenesis of ataxia telangiectasia.
McKinnon PJ
Annu Rev Pathol; 2012; 7():303-21. PubMed ID: 22035194
[TBL] [Abstract][Full Text] [Related]
10. [Ataxia-telangiectasia: a review].
Bott L; Thumerelle C; Cuvellier JC; Deschildre A; Vallée L; Sardet A
Arch Pediatr; 2006 Mar; 13(3):293-8. PubMed ID: 16423518
[TBL] [Abstract][Full Text] [Related]
11. Modeling ATM mutant proteins from missense changes confirms retained kinase activity.
Barone G; Groom A; Reiman A; Srinivasan V; Byrd PJ; Taylor AM
Hum Mutat; 2009 Aug; 30(8):1222-30. PubMed ID: 19431188
[TBL] [Abstract][Full Text] [Related]
12. Different clinical and immunological presentation of ataxia-telangiectasia within the same family.
Soresina A; Meini A; Lougaris V; Cattaneo G; Pellegrino S; Piane M; Darra F; Plebani A
Neuropediatrics; 2008 Feb; 39(1):43-5. PubMed ID: 18504682
[TBL] [Abstract][Full Text] [Related]
13. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
Micol R; Ben Slama L; Suarez F; Le Mignot L; Beauté J; Mahlaoui N; Dubois d'Enghien C; Laugé A; Hall J; Couturier J; Vallée L; Delobel B; Rivier F; Nguyen K; Billette de Villemeur T; Stephan JL; Bordigoni P; Bertrand Y; Aladjidi N; Pedespan JM; Thomas C; Pellier I; Koenig M; Hermine O; Picard C; Moshous D; Neven B; Lanternier F; Blanche S; Tardieu M; Debré M; Fischer A; Stoppa-Lyonnet D;
J Allergy Clin Immunol; 2011 Aug; 128(2):382-9.e1. PubMed ID: 21665257
[TBL] [Abstract][Full Text] [Related]
14. The ZFHX3 (ATBF1) transcription factor induces PDGFRB, which activates ATM in the cytoplasm to protect cerebellar neurons from oxidative stress.
Kim TS; Kawaguchi M; Suzuki M; Jung CG; Asai K; Shibamoto Y; Lavin MF; Khanna KK; Miura Y
Dis Model Mech; 2010; 3(11-12):752-62. PubMed ID: 20876357
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the porcine ATM gene: towards the generation of a novel non-murine animal model for Ataxia-Telangiectasia.
Rogatcheva MB; Fritz KL; Rund LA; Pollock CB; Beever JE; Counter CM; Schook LB
Gene; 2007 Dec; 405(1-2):27-35. PubMed ID: 17933474
[TBL] [Abstract][Full Text] [Related]
16. The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle.
Biton S; Barzilai A; Shiloh Y
DNA Repair (Amst); 2008 Jul; 7(7):1028-38. PubMed ID: 18456574
[TBL] [Abstract][Full Text] [Related]
17. The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants.
Hall J
Cancer Lett; 2005 Sep; 227(2):105-14. PubMed ID: 16112413
[TBL] [Abstract][Full Text] [Related]
18. ATM-mediated response to DNA double strand breaks in human neurons derived from stem cells.
Biton S; Gropp M; Itsykson P; Pereg Y; Mittelman L; Johe K; Reubinoff B; Shiloh Y
DNA Repair (Amst); 2007 Jan; 6(1):128-34. PubMed ID: 17178256
[TBL] [Abstract][Full Text] [Related]
19. Loss of ATM positively regulates the expression of hypoxia inducible factor 1 (HIF-1) through oxidative stress: Role in the physiopathology of the disease.
Ousset M; Bouquet F; Fallone F; Biard D; Dray C; Valet P; Salles B; Muller C
Cell Cycle; 2010 Jul; 9(14):2814-22. PubMed ID: 20676049
[TBL] [Abstract][Full Text] [Related]
20. Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia.
Lavin MF; Gueven N; Bottle S; Gatti RA
Br Med Bull; 2007; 81-82():129-47. PubMed ID: 17586848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
